- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
Invaio Sciences infused with series C funding
Alexandria Venture Investments has supported the life science technology developer in its $88.9m series C round which has pushed total funding past $142m.
Oct 24, 2021Ivi activates $250m series D
VTB has led the Prof-Media-backed video streaming service’s new round, which brought its overall funding to $434.7m.
Oct 24, 2021Recode Therapeutics records $80m series B
Osage University Partners has helped the UT Southwestern precision medicine spinout close a round which will be used to advance and expand its pipeline of respiratory disease drug candidates.
Oct 22, 2021Daily Deal Round Up: October 22, 2021
Automated driving software developer Jimu Intelligent raised over $31m from investors including UMC Capital and Avic Pingshan while Lockheed Martin took part in gyroscope technology developer Anello's $28m round.
Oct 22, 2021Daily deal net: October 22, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Oct 22, 2021360Learning turns to SoftBank in $200m round
The collaborative learning platform developer raised the cash in a round co-led by SoftBank Vision Fund 2 that will be boost hiring and research and development.
Oct 22, 2021Candy Digital catches $100m at $1.5bn valuation
SoftBank, Com2Us and CAA's Connect Ventures backed the digital collectibles platform developer in a series A round which will be used to accelerate the growth of its team.
Oct 22, 2021Recode Therapeutics records $80m series B
Pfizer and Sanofi helped the precision medicine developer close a series B round which will be used to advance and expand its pipeline of respiratory disease drug candidates.
Oct 22, 2021Animoca Brands gets its hands on $65m
Ubisoft, Smile Group and Com2uS all contributed to a round which pushed the blockchain game developer's valuation past $2.2bn.
Oct 22, 2021Clounix closes two rounds
The networking technology developer raised $62.6m between an Inspur Group-backed angel round and a pre-series A.
Oct 22, 2021D&D Pharmatech decides on $51m series C
Sumitomo Mitsui’s DS Asset Management subsidiary backed the neurological and metabolic disorder drug developer in a round that will support clinical trials.
Oct 22, 2021ShouTi shoots to $100m series B round
Eli Lilly, WuXi AppTec and Schrodinger were among the investors in the cardiovascular, pulmonary and metabolic disorder drug developer's latest round.
Oct 22, 2021Featured Content
GCV Powerlist 2026Nominations for the 2026 GCV Powerlist are now open. Use this form to nominate yourself or someone else.GCV Powerlist 2026
Nominations for the 2026 GCV Powerlist are now open. Use this form to nominate yourself or someone else.
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
Corporate venture building reportData from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomesCorporate venture building report
Data from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomes
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation


